Working... Menu

Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa) (EIROS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03333447
Recruitment Status : Recruiting
First Posted : November 7, 2017
Last Update Posted : July 18, 2018
BioClinica, Inc.
Information provided by (Responsible Party):
CEN Biotech

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Actual Primary Completion Date : September 13, 2017
  Estimated Study Completion Date : December 2019